Literature DB >> 31270465

Beneficial visual outcome of vitrectomy and delamination surgery for tractional complications of diabetic retinopathy in a cohort of black patients.

Jason Ho1, Tom H Williamson1, Roger S Wong1, D Alistair H Laidlaw2.   

Abstract

BACKGROUND/AIMS: Poor visual outcomes have recently been reported in black patients undergoing vitrectomy and delamination surgery for complications of proliferative diabetic retinopathy. We therefore investigated the outcome of surgery on a similar cohort of black patients and examined for potential predictors of visual success.
METHODS: A single-centre retrospective case review of consecutive black patients who underwent vitrectomy and delamination surgery for complications of PDR between July 2010 and September 2017. The primary outcome measure was change in visual acuity (VA) at 6 months post-operatively. Multiple linear regression analysis was performed to evaluate determinants of change in VA.
RESULTS: A total of 44 eyes of 44 patients were included. Mean age was 53.7 (range: 24.3-75.8) years. In all, 43% were male. A total of 52% had adjunctive pre-operative anti-VEGF therapy. Mean pre-operative VA was 1.49 logMAR ± 0.73 (range 0.18 to 2.6 logMAR). Mean change in VA at 6 months was a gain of 0.59 ± 0.94 logMAR (range 1.9 logMAR acuity loss to 2.5 logMAR acuity gain). Four cases required further surgery to treat rhegmatogenous detachment. The acuity of 68% improved by 0.3 or more logMAR. Silicone oil was used as primary tamponade in 7%. Pre-operative VA and use of silicone oil significantly predicted VA decline at 6 months (p = 0.001 and p = 0.007).
CONCLUSIONS: The majority of our cohort derived visual benefit from vitrectomy and delamination for PDR-related complications. Improvement in VA was comparable to outcomes from the UK National Ophthalmic Database report. Silicone oil should be avoided these patients if possible.

Entities:  

Year:  2019        PMID: 31270465      PMCID: PMC7002724          DOI: 10.1038/s41433-019-0496-x

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  15 in total

1.  Silicone oil in diabetic vitrectomy.

Authors:  D McLeod
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

2.  Outcomes of vitrectomy for advanced diabetic retinopathy at Groote Schuur Hospital, Cape Town, South Africa.

Authors:  J C Rice; J Steffen
Journal:  S Afr Med J       Date:  2015-06

3.  [The predictive value of a classification for proliferative diabetic vitreoretinopathy].

Authors:  Lutz Hesse; Günther Heller; Nicola Kraushaar; Alexandra Wesp; Bernd Schroeder; Peter Kroll
Journal:  Klin Monbl Augenheilkd       Date:  2002 Jan-Feb       Impact factor: 0.700

Review 4.  Surgical management of the late complications of proliferative diabetic retinopathy.

Authors:  D K Newman
Journal:  Eye (Lond)       Date:  2010-02-05       Impact factor: 3.775

5.  Recognition of vitreoschisis in proliferative diabetic retinopathy. A useful landmark in vitrectomy for diabetic traction retinal detachment.

Authors:  S D Schwatz; R Alexander; P Hiscott; Z J Gregor
Journal:  Ophthalmology       Date:  1996-02       Impact factor: 12.079

6.  Bevacizumab as an adjunct to vitreoretinal surgery for diabetic retinopathy in East Africa.

Authors:  G Guthrie; A B Hall; K Dhalla; R M Davies; R M Davis; D H Steel
Journal:  Eye (Lond)       Date:  2013-08-16       Impact factor: 3.775

7.  The Royal College of Ophthalmologists' National Ophthalmology Database Study of Vitreoretinal Surgery: Report 6, Diabetic Vitrectomy.

Authors:  Timothy L Jackson; Robert L Johnston; Paul H J Donachie; Tom H Williamson; John M Sparrow; David H W Steel
Journal:  JAMA Ophthalmol       Date:  2016-01       Impact factor: 7.389

8.  Black patients sustain vision loss while White and South Asian patients gain vision following delamination or segmentation surgery for tractional complications associated with proliferative diabetic retinopathy.

Authors:  R Mastropasqua; Y H-L Luo; Y S Cheah; C Egan; J J Lewis; L da Cruz
Journal:  Eye (Lond)       Date:  2017-06-02       Impact factor: 3.775

Review 9.  Current management of diabetic tractional retinal detachments.

Authors:  Michael W Stewart; David J Browning; Maurice B Landers
Journal:  Indian J Ophthalmol       Date:  2018-12       Impact factor: 1.848

10.  Antivascular endothelial growth factor agents pretreatment before vitrectomy for complicated proliferative diabetic retinopathy: a meta-analysis of randomised controlled trials.

Authors:  Xin-Yu Zhao; Song Xia; You-Xin Chen
Journal:  Br J Ophthalmol       Date:  2017-12-15       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.